Franchise opportunities compared

    Amerisourcebergen Drug vs Tijon Fragrance Lab

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Initial investment · Item 7

    Amerisourcebergen Drug

    $5,000 – $12,000

    2026 FDD · Item 7 · PDF p. 29

    Tijon Fragrance Lab

    Not available

    Initial franchise fee · Item 5

    Amerisourcebergen Drug

    Not available

    Tijon Fragrance Lab

    $29,750

    2026 FDD · Item 5 · PDF p. 4

    Royalty · Item 6

    Amerisourcebergen Drug

    Not available

    Tijon Fragrance Lab

    $6.00 Total Gross Receipts

    2026 FDD · Item 6 · PDF p. 17

    Before you compare

    • Both sets of figures come from 2026 FDDs.
    • Only neither brand has reviewed Item 19 figures here.

    Financial commitment

    Estimated initial investment (Item 7)

    Amerisourcebergen Drug

    $5,000 – $12,000
    xisting pharmacy with no GNP Private Label product on your shelves we estimate an investment of — 5000
    2026 FDD · Item 7 · PDF p. 29

    Tijon Fragrance Lab

    Not available
    No reviewed Item 7 total
    Standard initial franchise fee (Item 5)

    Amerisourcebergen Drug

    Not available
    No single standard fee identified

    Tijon Fragrance Lab

    $29,750
    2026 FDD · Item 5 · PDF p. 4
    Royalty (Item 6)

    Amerisourcebergen Drug

    Not available
    No reviewed royalty record

    Tijon Fragrance Lab

    $6.00 Total Gross Receipts
    Royalty Fee
    2026 FDD · Item 6 · PDF p. 17
    Brand / advertising fund (Item 6)

    Amerisourcebergen Drug

    Not available
    No reviewed brand or advertising fund fee

    Tijon Fragrance Lab

    $0.00
    Advertising Fee — Total Gross Receipts; may be required after a minimum of twenty-five (25) franchises are open for business
    2026 FDD · Item 6 · PDF p. 18

    System scale & health

    Total outlets (Item 20)

    Amerisourcebergen Drug

    2,361
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 55

    Tijon Fragrance Lab

    Not available
    No reviewed outlet counts
    Net outlet change (Item 20)

    Amerisourcebergen Drug

    +2,162
    Calculated: 199 at end of 2023 → 2,361 at end of 2025

    Tijon Fragrance Lab

    Not available
    Only one year reported
    Outlet exits (Item 20)

    Amerisourcebergen Drug

    Not available
    No complete exit records for a year

    Tijon Fragrance Lab

    Not available
    No complete exit records for a year
    Franchising since (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    Tijon Fragrance Lab

    Not available
    Not in reviewed records
    Franchisor founded (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    Tijon Fragrance Lab

    2017
    2026 FDD · Item 1 · PDF p. 54

    Financial performance (Item 19), by location group

    Amerisourcebergen Drug

    No reviewed Item 19 figures

    Tijon Fragrance Lab

    Not disclosed — no Item 19 financial performance representation

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Amerisourcebergen Drug vs Tijon Fragrance Lab: common questions

    Do Amerisourcebergen Drug and Tijon Fragrance Lab disclose financial performance (Item 19)?
    Amerisourcebergen Drug has no reviewed Item 19 figures on file; Tijon Fragrance Lab makes no Item 19 financial performance representation. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures

    Keep researching